+33 1 76 70 47 90 / creativ@creativ-ceutical.com

[PRS51] Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands

[PRS51] Exploring The Burden of Illness and Impact of SQ-Standardised Grass Allergy Immunotherapy Tablet Treatment (AIT) on Quality of Life (QOL) in Patients with Allergic Rhinitis (AR) in Germany and The Netherlands

2017 ISPOR 20TH ANNUAL EUROPEAN CONGRESS

Germain, N. | Aballéa, S. | Romano, M. | Hawken, N. A. | Toumi, M. | Volume: 20, Issue: 9, Pages: A648,
https://www.doi.org/10.1016/j.jval.2017.08.1507